Tag:

Johnson & Johnson

Tylenol Murders Suspect Found Dead In Massachusetts Apartment Tylenol Murders Suspect Found Dead In Massachusetts Apartment
Tylenol Murders Suspect Found Dead In Massachusetts Apartment The prime suspect in a crime that killed seven people was found dead in Massachusetts, officials say.  James Lewis, who claimed responsibility for the 1982 Tylenol murders, was found dead in Cambridge in an apartment on Gore Street around 4 p.m. on Sunday, July 9, according to the Cambridge Police Department.  He was declared dead shortly after first responders arrived at the scene.  An initial investigation determined that his death was not suspicious.  Lewis wrote a letter to Johnson & Johnson claiming responsibility for tampering with Tylenol products and demand…
COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed
Covid-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed Warning that "many variants are coming," the chairman and chief executive officer of Pfizer says a fourth dose of the COVID-19 -- a second booster shot -- will be needed. Appearing on CBS-TV's "Face the Nation" on Sunday, March 13, Dr. Albert Bourla was asked if a COVID booster shot could become recommended each fall - similar to a flu shot. "I think so," Bourla responded. "And I think this is what we are trying now to make." Bourla said Pfizer is trying "very diligently to stay ahead of the virus" because "many variants are coming and Omicron was the first one that was able to evade in a …
COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say
Covid-19: Johnson & Johnson Pauses Vaccine Production, Reports Say The only Johnson & Johnson facility currently making viable batches of the company's one-dose COVID-19 vaccine has temporarily halted its production, according to a new report. According to The New York Times, Johnson & Johnson has stopped production of its current vaccine, potentially to create a more profitable version aimed at other viruses. With production on hold at its Dutch facility in the city of Leiden, hundreds of millions of doses could be taken out of circulation, though it is unclear how vaccine supplies in the US have been affected. Ayoade Alakija, a co-head of the A…
COVID-19: Moderna Vaccine Gets Full Approval From FDA COVID-19: Moderna Vaccine Gets Full Approval From FDA
Covid-19: Moderna Vaccine Gets Full Approval From FDA Federal officials have granted full approval to Moderna’s COVID-19 vaccine following its authorization last year for emergency use. On Monday, Jan. 31, the Food and Drug Administration (FDA) announced that Moderna’s vaccine has been granted its full approval, joining the Pfizer shot which was authorized months ago. The move comes after tens of millions of doses of the Moderna vaccine have already been administered across the country. It also represents Moderna’s first FDA-approved product in the US. Officials said the FDA reviewed months of additional follow-up data submitted by Moderna to…
COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots
Covid-19: CDC Shortens Waiting Period For Pfizer Booster Shots Americans who received the Pfizer and BioNTech COVID-19 vaccine can now get a booster shot in a shorter timeframe than originally recommended, according to federal health officials who passed a pair of measures to make the vaccine more readily available. The US Centers for Disease Control and Prevention (CDC) announced on Tuesday, Jan. 4 that booster shots should be made available five months after receiving the second dose of the vaccine, down from the original recommendation of at least six months. Those who received the Moderna vaccine must still wait at least six months after their seco…
COVID-19: CDC Cuts Isolation Time In Half For Those Not Displaying Symptoms COVID-19: CDC Cuts Isolation Time In Half For Those Not Displaying Symptoms
Covid-19: CDC Cuts Isolation Time In Half For Those Not Displaying Symptoms The Centers for Disease Control and Prevention (CDC) has shortened the amount of time it recommends people isolate if they have contracted COVID-19 and are not experiencing symptoms. The CDC said in an announcement on Monday, Dec. 27, that based on what is currently known about COVID-19 and the Omicron variant, it is reducing the recommended time for isolation from 10 days to five days for those who have tested positive and are asymptomatic.  After leaving isolation, people should wear a mask for the next five days when around others, the CDC said. Health officials said those who are …
COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab
Covid-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab The Centers for Disease Control and Prevention (CDC) issued new guidance saying that people shouldn’t get the one-dose Johnson & Johnson COVID-19 shot if the Pfizer or Moderna option is available. Citing potentially life-threatening blood clots liked to the J & J jab, the CDC’s Advisory Committee on Immunization Practices (ACIP) met on Thursday, Dec. 16 following an update from the Food and Drug Administration. Federal officials halted the use of the Johnson & Johnson vaccine earlier this year for 10 days in April after six women experienced the blood-clotting problem — the only…
COVID-19: Pfizer Expected To Seek Approval For Boosters For All Adults COVID-19: Pfizer Expected To Seek Approval For Boosters For All Adults
Covid-19: Pfizer Expected To Seek Approval For Boosters For All Adults Pfizer and European partner BioNTech are expected to seek federal authorization to administer its COVID-19 booster shot to all Americans over the age of 18. As soon as this week, the biopharmaceutical company is reportedly planning to seek US Food and Drug Administration (FDA) approval for booster shots for anyone 18 and older. Currently, only Americans 65 and older, those who are immunocompromised and anyone whose job puts them at a larger risk for exposure are eligible for Pfizer booster shots. The FDA is considered likely to grant the request, potentially before Thanksgiving and the hol…
COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says
Covid-19: Immunocompromised People May Need Fourth Dose, CDC Says Some Americans may require a fourth shot of the COVID-19 vaccine if they are immunocompromised, according to new federal guidance. The Centers for Disease Control and Prevention (CDC), said that adults 18 and older who received the Pfizer or Moderna COVID-19 vaccines and are moderately or severely immunocompromised may get a fourth dose at least six months after getting their third shot, the guidance states. Officials cautioned that Johnson & Johnson recipients “should not receive more than two COVID-19 vaccine doses,” though a second is recommended. The CDC authorized a thir…
COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans
Covid-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans The Food and Drug Administration has authorized the use of Johnson & Johnson and Moderna COVID-19 booster shots for millions of people across the United States. The FDA made the announcement on Wednesday afternoon, Oct. 20, nearly a month after the agency authorized the use of a Pfizer COVID-19 booster shot.  The agency said a single booster dose of the Moderna vaccine can be administered at least six months after the two-dose vaccine series is complete in the following groups of people: 65 years of age and older 18 through 64 years of age at high risk of severe COVID-19 18 …
COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot
Covid-19: Johnson & Johnson To Seek Authorization For Booster Shot Johnson & Johnson is seeking federal approval for its COVID-19 booster shots, which could make it the latest to be authorized by the US Food and Drug Administration (FDA). On Monday, Oct. 4, a spokesperson for the pharmaceutical company announced that they were looking to gain approval to begin administering booster shots for its one-dose vaccine. Last month, regulators authorized a booster shot for some recipients of the Pfizer vaccine and are considering authorization this month for recipients of the Moderna vaccine. In total, according to reports, more than 15 million Am…
COVID-19: School District In Region Considering Vaccine Mandate COVID-19: School District In Region Considering Vaccine Mandate
Covid-19: School District In Region Considering Vaccine Mandate A school district in Western Massachusetts is considering a COVID-19 vaccination mandate to go along with orders to wear facial coverings while in school buildings. Officials in the Amherst-Pelham Regional School District are considering taking the extra step to provide extra protection against the spread of the virus by mandating faculty and staff members all get the COVID-19 vaccine. The decision will now move forward to a special school committee vote. Officials noted that if mandated, particular religious and health exemptions would have to be agreed upon between the school and its se…
COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations
Covid-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations The Centers for Disease Control and Prevention (CDC) has released a new study that found which of the three US-approved COVID-19 vaccines are most effective in preventing hospitalizations, ICU visits, or potential intubation. A recently released study from the CDC determined that the Moderna vaccine was slightly more effective in preventing hospitalizations than the Pfizer or Johnson & Johnson vaccines. In total, approximately 32,000 patients that were treated in hospitals in nine US states were studied by the CDC over the summer and it was determined that the Moderna shot was most effe…
COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations
Covid-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations The Centers for Disease Control and Prevention (CDC) has released a new study that found which of the three US-approved COVID-19 vaccines are most effective in preventing hospitalizations, ICU visits, or potential intubation. A recently released study from the CDC determined that the Moderna vaccine was slightly more effective in preventing hospitalizations than the Pfizer or Johnson & Johnson vaccines. In total, approximately 32,000 patients that were treated in hospitals in nine US states were studied by the CDC over the summer and it was determined that the Moderna shot was most effe…
COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot
Covid-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot The timeline for COVID-19 booster shots may be accelerated as the US Food and Drug Administration (FDA) is expected to approve booster shots for all Americans after six months, not eight, as previously announced. According to reports, as more data is examined by federal health officials, it is more likely that booster shots will be required sooner than later for the Pfizer and Moderna vaccines. Before they can go into arms, the FDA must authorize booster shots for each vaccine. A spokesperson for the agency said that under its general policy it "cannot comment on or confirm the existence" o…
COVID-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected COVID-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected
Covid-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected The US Food and Drug Administration (FDA) has granted full approval to the Pfizer/BioNTech COVID-19 vaccine for anyone 16 and older. On Monday, Aug. 23, the FDA announced that the Pfizer vaccine has been granted full approval, which is expected to potentially open the door for more COVID-19 vaccine mandates. The Pentagon will mandate vaccines for its 1.4 million active-duty service members, following the FDA approval Monday. United Airlines recently said its employees will be required to show proof of vaccination within five weeks of regulatory approval.  Pfizer is the first COVID-1…
COVID-19: CDC Announces Starting Date For Booster Shots COVID-19: CDC Announces Starting Date For Booster Shots
Covid-19: CDC Announces Starting Date For Booster Shots Federal health officials have set a date for when they plan to begin rolling out COVID-19 booster shots to help curtail the spread of new variants of the virus. Citing new data that showed Pfizer and Moderna vaccines’ effectiveness wanes over time, President Joe Biden’s administration announced that beginning the week of Monday, Sept. 20, booster shots would be made available for many Americans. Earlier story - COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) sa…